Meredith A. Tennis, Ph.D. - Publications

Affiliations: 
2006 Georgetown University Medical Center, Washington, DC, United States 
Area:
Oncology, Molecular Biology, Epidemiology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Blomberg R, Sompel K, Hauer C, Smith AJ, Peña B, Driscoll J, Hume PS, Merrick DT, Tennis MA, Magin CM. Hydrogel-Embedded Precision-Cut Lung Slices Model Lung Cancer Premalignancy Ex Vivo. Advanced Healthcare Materials. e2302246. PMID 37953708 DOI: 10.1002/adhm.202302246  0.476
2023 Blomberg R, Sompel K, Hauer C, Pe A B, Driscoll J, Hume PS, Merrick DT, Tennis MA, Magin CM. Tissue-engineered models of lung cancer premalignancy. Biorxiv : the Preprint Server For Biology. PMID 36993773 DOI: 10.1101/2023.03.15.532835  0.458
2023 Sompel K, Smith AJ, Hauer C, Elango AP, Clambey ET, Keith RL, Tennis MA. Precision cut lung slices as a preclinical model for non-small cell lung cancer chemoprevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 36888650 DOI: 10.1158/1940-6207.CAPR-23-0004  0.389
2022 Dwyer-Nield L, Keith RL, Tennis MA. Protocol for intranasal chemoprevention delivery in a urethane mouse lung cancer model. Star Protocols. 3: 101750. PMID 36201319 DOI: 10.1016/j.xpro.2022.101750  0.416
2022 Sompel K, Dwyer-Nield LD, Smith AJ, Elango AP, Vanderlinden LA, Kopf K, Keith RL, Tennis MA. Loss of Frizzled 9 in Lung Cells Alters Epithelial Phenotype and Promotes Premalignant Lesion Development. Frontiers in Oncology. 12: 815737. PMID 35924166 DOI: 10.3389/fonc.2022.815737  0.369
2022 Dwyer-Nield LD, McArthur DG, Hudish TM, Hudish LI, Mirita C, Sompel K, Smith AJ, Alavi K, Ghosh M, Merrick DT, Tennis MA, Keith RL. PPARgamma agonism inhibits progression of premalignant lesions in a murine lung squamous cell carcinoma model. International Journal of Cancer. PMID 35830207 DOI: 10.1002/ijc.34210  0.323
2022 Sompel K, Dwyer-Nield LD, Smith AJ, Elango A, Backos DS, Zhang B, Gross J, Ternyak K, Matsuda JL, Kopf K, Keith RL, Tennis MA. Iloprost requires the Frizzled-9 receptor to prevent lung cancer. Iscience. 25: 104442. PMID 35707728 DOI: 10.1016/j.isci.2022.104442  0.454
2021 Tennis MA, Smith AJ, Dwyer-Nield LD, Keith RL. Intranasal iloprost prevents tumors in a murine lung carcinogenesis model. Cancer Prevention Research (Philadelphia, Pa.). PMID 34556494 DOI: 10.1158/1940-6207.CAPR-21-0086  0.435
2018 New ML, White CM, McGonigle P, McArthur DG, Dwyer-Nield LD, Merrick DT, Keith RL, Tennis MA. Prostacyclin and EMT pathway markers for monitoring response to lung cancer chemoprevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 30045935 DOI: 10.1158/1940-6207.CAPR-18-0052  0.47
2017 Bauer AK, Upham BL, Rondini EA, Tennis MA, Velmuragan K, Wiese D. Toll-like receptor expression in human non-small cell lung carcinoma: potential prognostic indicators of disease. Oncotarget. 8: 91860-91875. PMID 29190881 DOI: 10.18632/Oncotarget.19463  0.356
2017 Dwyer-Nield LD, Hickey GA, Friedman M, Choo K, McArthur DG, Tennis MA, New ML, Geraci M, Keith RL. The Second Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model. Cancer Prevention Research (Philadelphia, Pa.). PMID 28851689 DOI: 10.1158/1940-6207.CAPR-17-0050  0.362
2017 Bauer AK, Upham BL, Rondini EA, Tennis MA, Velmuragan K, Wiese D. Toll-like receptor expression in human non-small cell lung carcinoma: potential prognostic indicators of disease. Oncotarget. PMID 28778074 DOI: 10.18632/oncotarget.19463  0.356
2015 Fritz JM, Tennis MA, Orlicky DJ, Yin H, Ju C, Redente EF, Choo KS, Staab TA, Bouchard RJ, Merrick DT, Malkinson AM, Dwyer-Nield LD. Corrigendum: depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas. Frontiers in Immunology. 6: 88. PMID 25784911 DOI: 10.3389/Fimmu.2015.00088  0.319
2014 Fritz JM, Tennis MA, Orlicky DJ, Lin H, Ju C, Redente EF, Choo KS, Staab TA, Bouchard RJ, Merrick DT, Malkinson AM, Dwyer-Nield LD. Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas. Frontiers in Immunology. 5: 587. PMID 25505466 DOI: 10.3389/Fimmu.2014.00587  0.386
2012 Tennis MA, Vanscoyk MM, Wilson LA, Kelley N, Winn RA. Methylation of Wnt7a is modulated by DNMT1 and cigarette smoke condensate in non-small cell lung cancer. Plos One. 7: e32921. PMID 22403725 DOI: 10.1371/Journal.Pone.0032921  0.325
2010 Tennis MA, Van Scoyk MM, Freeman SV, Vandervest KM, Nemenoff RA, Winn RA. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer. Molecular Cancer Research : McR. 8: 833-43. PMID 20501643 DOI: 10.1158/1541-7786.Mcr-09-0400  0.369
2010 Tennis MA, Vanscoyk M, Keith RL, Winn RA. The role of prostacyclin in lung cancer. Translational Research : the Journal of Laboratory and Clinical Medicine. 155: 57-61. PMID 20129485 DOI: 10.1016/j.trsl.2009.06.010  0.473
2007 Tennis M, Van Scoyk M, Winn RA. Role of the Wnt signaling pathway and lung cancer Journal of Thoracic Oncology. 2: 889-892. PMID 17909349 DOI: 10.1097/JTO.0b013e318153fdb1  0.405
2006 Tennis M, Krishnan S, Bonner M, Ambrosone CB, Vena JE, Moysich K, Swede H, McCann S, Hall P, Shields PG, Freudenheim JL. p53 Mutation analysis in breast tumors by a DNA microarray method. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 80-5. PMID 16434591 DOI: 10.1158/1055-9965.Epi-05-0444  0.313
2005 Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson BN, Shields PG, Tennis M, Czene K. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7467-74. PMID 16234513 DOI: 10.1200/Jco.2005.01.7335  0.388
Show low-probability matches.